This brand name is authorized in Nigeria.
The drug METAZINE contains one active pharmaceutical ingredient (API):
1
|
UNII
R61ZEH7I1I - PROMETHAZINE HYDROCHLORIDE
|
|
Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| 04-7921 | Syrup | Metazine Syrup SYRUP 5 mg/5 mL 1 x 60 mL, 1 x 100 mL (in amber PET bottles) | Syrup A clear, light-yellow syrup METAZINE SYRUP 04-7921 METAZINE SYRUP Each 5ml contains: Promethazine Hydrochloride BP 5mg, Ethanol (96%) BP 0.25ml, Sucrose BP 3400mg, Citric Acid Anhydrous BP 36mg, Sodium Citrate BP 140mg, Sodium Sulphite BP 5mg, Sodium Metabisulphite BP 5mg, Ascorbic Acid BP 12mg, Caramel Colour USP 1.5mg, Sodium Benzoate BP 5mg, Orange Flavour 0.0125ml, Purified Water BP ……..qs.. 5ml. Drugs ALIMENTARY TRACT AND METABOLISM Drugs UNIQUE PHARMACEUTICALS LIMITED, FATAI ATERE WAY MATORI, MUSHIN LAGOS LAGOS 8097421000 UNIQUE PHARMARCEUTICALS LIMITED, 11, FATAI ATERE WAY, MATORI, MUSHIN, LAGOS., Nigeria 2/23/2023 2/22/2028 | 23/02/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R06AD02 | Promethazine | R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AD Phenothiazine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | 04-7921 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.